Click "Begin a Submission" under the category of your choice below to submit an abstract.
Don’t miss out on a great opportunity to submit your late-breaking abstract now for the ONS 43rd Annual Congress, May 17-20, 2018, in Washington, DC.
Abstract presentations are focused in areas of quality improvement, and clinical/evidence-based practice projects. Selection of abstracts will be based solely on a blind peer review. Abstracts may be selected for oral presentation sessions or ePoster presentations, and all accepted abstracts are published in the online Oncology Nursing Forum .
Please note: accepted abstracts cannot be edited after acceptance and will be published as received. Pay close attention to spelling, grammar, names, and credentials. Primary authors may submit only one abstract for consideration.
Primary authors must be either a registered nurse, a licensed healthcare professional from another discipline (physician, pharmacist, physical therapist, etc.), or a doctorally-prepared individual.
For abstracts with more than one author, the primary author is the sole contact person and presenter. A primary author may only submit one abstract for consideration. Institutions or groups submitting more than one abstract with common authors must designate a different primary author for each abstract. Abstracts may not have more than six total authors.
Authors (including students) or institutions cannot submit multiple abstracts on the same topic or from the same topic. If data are from a multi-site study, each site may submit one abstract.
Abstracts submitted must be of the author’s own completed work, work in progress, or work previously presented at the local or regional level. However, abstracts may not be submitted that contain information that has been previously published or presented to national or international oncology nursing audiences.
All abstract submitters will need to complete the following forms order to meet the ONS CNE Provider Unit requirements. These forms are available in the abstract submission system.
Financial relationships are relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g. stocks, stock options, or other ownership interest, excluding diversified mutual fund(s), or other financial benefit. Financial relationships can also include “contracted research” where the institution gets the grant and manages the funds and the individual is the principal or named investigator on the grant. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ANCC considers relationships of the person involved in the CNE activity to include financial relationships of a spouse or significant other. A relevant financial relationship is any relationship in any amount occurring in the past 12 months (as of the date that the form is completed) that creates a conflict of interest. There is a lot of press recently on commercial influence over continuing education in medicine and nursing. It’s important to identify potential conflicts to the planning team as well as to the audience. Without this information, there is not full disclosure. Without full disclosure there is the implication there is information to hide and bias is inherent in hiding information.
Warrant that you are the author of your presentation, that the presentation is original, except for such excerpts from copyrighted material included with the permission of the copyright owner and that you indemnify or release ONS against any and all liabilities, claims, or damages that would arise. You agree that the presentation is your own work, excerpts of copyright of materials are used with the expressed permission of the owner, presentation has not been developed as part of another presentation, and that it may be included within the ONS marketing materials.
Oral Abstracts
Abstracts accepted for oral presentations are offered in a session with four to six other abstracts and grouped by related category to be delivered for presentation. Speakers generally have 10-15 minutes to present their abstract and should include time for questions and answers. Only ONE AUTHOR (primary or first author) may present the oral presentation session. Primary authors of abstracts selected for a podium presentation will be asked to submit a PowerPoint presentation.
ePoster Abstracts
The submitter’s prepared poster will display the process and outcome of a scientific or professional project. All presenters will submit their electronic poster directly to the ePoster vendor. Further directions and ePoster specifications will be provided after acceptance. ePosters are available for viewing before, during, and after Congress. Authors of accepted ePoster abstracts MUST be present at the assigned presentation monitor during their assigned session at the conference to allow for dialog with participants.
Abstracts will be scored using a 1-5 ranking on the following six criteria.
Topic Significance and Study Purpose/Background/Rationale
Methods, Intervention, and Analysis
Findings and Interpretation
Discussion and Implications
Presentation
Innovative
Industry-supported abstracts are identified as projects that the researcher or presenter are employees of a pharmaceutical or related company. Also, any project that has been solely funded or directed by a company would be considered industry supported. Projects that have received unrestricted grant funding in which the researcher or principal investigator maintained full control over the project would not be considered industry supported.
Pharmaceutical company or industry employees may submit an abstract featuring their employer’s products or services if they fully disclose their employment and/or financial involvement. Abstract presentations may not be sales presentations and must not imply the Society’s endorsement of said products or services. The individual making the presentation must clarify this point during the presentation. All pharmaceutical or industry sponsored abstracts are strongly encouraged to address nursing role, implications for nursing research, or clinical practice.
Researchers wishing to submit an abstract containing data related to a clinical pharmaceutical or industry trial conducted at their institution, must provide full disclosure of the presenter’s affiliation with the company, any financial gains (honoraria, travel reimbursement etc.) received, research support obtained, or involvement of the company in the research, as well as a complete list of all contributors (physicians, statisticians etc.) on the abstract submission. Failure to provide such disclosure will result in the automatic rejection of the abstract. The member is expected to add a nursing dimension to the existing clinical trial data to make such data interesting and applicable to the conference attendees.
Primary authors may decline acceptance or withdraw presentation of an abstract selection by emailing absquestion@ons.org. The accepted abstracts will be presented as ePosters in the Learning Hall during exhibit time. No CNE will be awarded for these abstracts due to ANCC guidelines stating that content must be free of commercial influence.
ePoster Abstracts
The submitter’s prepared poster will display the process and outcome of a scientific or professional project. All presenters will submit their electronic poster directly to the ePoster vendor. Further directions and ePoster specifications will be provided after acceptance. ePosters are available for viewing before, during, and after Congress. Authors of accepted ePoster abstracts MUST be present at the assigned presentation monitor during their assigned session at the conference to allow for dialog with participants.
Abstracts will be scored using a 1-5 ranking on the following seven criteria.
Significance and Background
Purpose
Interventions
Evaluation
Discussion
Presentation
Innovative
Forgotten ID and password?
We will email it to you.